AstraZeneca AB (manufacturing of tablets, testing, packaging of medicinal product, batch release)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 60 mg ATC: B01AC24
-
The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 90 mg ATC: B01AC24
-
The drug is prescribed to adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of atherothrombotic events.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 90 mg ATC: B01AC24
-
The drug is prescribed to adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 60 mg ATC: B01AC24